Immune Engineering SIG

Timeslot: Saturday, April 6, 2019 - 10:30am to 12:30pm
Track: Immunomodulatory Biomaterials
Room: Yakima 1


Abstracts will be available for download on April 3, 2019.

  • 10:30:00 AM 477. Human Pancreas Organ Slices as a Platform for Investigating the Immunopathological Processes of Type 1 Diabetes, E. Phelps*, C. Mathews; University of Florida, Gainesville, FL, USA

  • 10:45:00 AM 478. Apolipoproteins are a Mediator of Tissue-Specificity in the Foreign Body Response, K. Sadtler*(1,2), C. MacIsaac(1), F. Zepeda(1), J. Doloff(1,2), R. Langer(1,2), D. Anderson(1,2); (1)Massachusetts Institute of Technology, Cambridge, MA, USA, (2)Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

  • 11:00:00 AM 479. Delivery of STING Agonist for Augmenting Adoptive T Cell Therapy, C. Park*(1,2), J. Moon(1,2,3); (1)Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA, (2)Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA, (3)Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA

  • 11:15:00 AM 480. Depleting Myeloid-derived Suppressor Cells with Janus Synthetic Nanoparticle Antibodies As A Cancer Immunotherapy, J. Liu(1,2), R. Toy*(1), P. Pradhan(1), K. Roy(1,2); (1)Georgia Institute of Technology, Atlanta, GA, USA, (2)Emory University, Atlanta, GA, USA

  • 11:30:00 AM 481. Self-Assembly of Immune Signals to Identify Tolerogenic Factors in a Multiple Sclerosis Model, R. Oakes*(1), L. Tostanoski(1), C. Jewell(1,2,3); (1)University of Maryland - College Park, College Park, MD, USA, (2)Robert E. Fischell Institute for Biomedical Devices, College Park, MD, USA, (3)Department of Veterans Affairs, Baltimore, MD, USA

  • 11:45:00 AM 482. Effects of Tunable Degradation on Humoral, Cellular, and Protective Immune Responses Generated by a Universal Flu Vaccine Formulated with Acetalated Dextran Microparticles, K. Ainslie*(1), N. Chen(2), M. Collier(3), M. Gallovic(4), J. Ting(1), E. Bachelder(1); (1)University of North Carolina, Chapel Hill, NC, USA, (2)Pfizer, Beijing, China, (3)Avanti Polar Lipids, Inc., Alabaster, AL, USA, (4)IMMvention Therapuetix, Durham,

  • 12:00:00 PM 483. Local Anchoring of Indoleamine 2, 3-Dioxygenase Ameliorates Inflammation, S. Freeman*(1), E. Bracho-Sanchez(1), F. Rocha(1), S. Farhadi(1), S. Wallet(2), G. Hudalla(1), B. Keselowsky(1); (1)University of Florida, Gainesville, FL, USA, (2)East Carolina University, Greenville, NC, USA

  • 12:15:00 PM 484. Polymeric Nanoparticles Improve Antibody Delivery to Tumors and Tumor Draining Lymph Nodes to Enhance Cancer Immunotherapy via Checkpoint Inhibition, D. Francis*, A. Schudel, N. Rohner, S. Thomas; Georgia Institute of Technology, Atlanta, GA, USA